ESSA Pharma
EPIX
EPIX was delisted on the 8th of October, 2025.
31 hedge funds and large institutions have $185M invested in ESSA Pharma in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 4 closing their positions.
1,125% more call options, than puts
Call options by funds: $245K | Put options by funds: $20K
0.17% more ownership
Funds ownership: 79.2% → 79.37% (+0.17%)
6% less funds holding
Funds holding: 33 → 31 (-2)
38% less capital invested
Capital invested by funds: $297M → $185M (-$112M)
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$3.95M |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$219K |
| 3 |
Two Sigma Investments
New York
|
+$65.6K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$35.2K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$12.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
-$1.07M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$675K |
| 3 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$672K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$335K |
| 5 |
TAM
Tucker Asset Management
Littleton,
Colorado
|
-$137K |
EPIX Hedge Fund Activity: Q2 2024 in Review
31 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in ESSA Pharma (EPIX) for Q2 2024, worth a combined $185M — down 38% from $297M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of EPIX and 2 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 6 added.
The largest buyer was Soleus Capital Management, adding an estimated $3.95M. The largest seller was Janus Henderson Group, cutting an estimated $1.07M.
- 31 institutional investors held ESSA Pharma (EPIX) as of Q2 2024, down from 33 in Q1 2024.
- Funds reported $185M of ESSA Pharma stock for Q2 2024, down 38% quarter-over-quarter.
- 2 funds opened new ESSA Pharma positions in Q2 2024 and 4 closed out, a net change of -2 holders.
- The largest ESSA Pharma buyer in Q2 2024 was Soleus Capital Management, an estimated $3.95M added.
- The largest ESSA Pharma seller in Q2 2024 was Janus Henderson Group, an estimated $1.07M sold.
Based on aggregated 13F filings for Q2 2024.